TL;DR
MED-EL has launched TICI Unico, a cochlear implant designed to place its components, including the microphone, beneath the skin. The company says it has no externally visible hardware and is intended for continuous use, including during sleep and water activities; details on availability, eligibility and clinical performance were not provided in the source report.
MED-EL has launched TICI Unico, a cochlear implant designed to place its microphone and other components beneath the skin, with no externally visible hardware during everyday use. The product marks the company’s move from feasibility work and early European surgeries to a commercial device, though the source report does not specify where or when it will be available to patients.
Conventional cochlear implants use an external sound processor worn behind the ear or on the head. MED-EL says TICI Unico is designed to function entirely beneath the skin, including its microphone. The company describes it as the world’s only totally invisible cochlear implant; that is a company claim, and the report does not provide an independent comparison of competing products.
The launch follows earlier feasibility study results for MED-EL’s TICI platform and early surgeries in Europe, according to The Hearing Review. The report characterizes Unico as the commercial product resulting from that research and clinical work, but does not give study data, participant numbers, regulatory clearances or details about the surgeries.
MED-EL says the implant is designed for use without removing an external processor for activities such as sleeping, showering and swimming. The report says the device is not affected by water because it is implanted beneath the skin. It does not describe the device’s battery or charging method, microphone performance in different settings, or any limits on water exposure.
A New Approach to Implant Visibility
By designing a cochlear implant without visible external components, MED-EL is addressing a longstanding goal in the field: making implanted hearing technology less apparent to other people and reducing the need to wear an external processor. For some prospective users, discretion and the convenience of keeping a device in place during daily activities may affect whether they consider an implant.
The launch also puts attention on whether a fully implanted system can meet users’ needs across different environments and routines. TICI Unico’s practical value will depend on factors such as sound quality, reliability, charging, maintenance and clinical outcomes. The source report does not provide evidence on those measures, so the announcement establishes the product’s design and launch, not how it performs compared with conventional implants.
From Feasibility Work to Launch
Fully and totally implantable cochlear implant designs have drawn growing industry attention as manufacturers explore ways to reduce or remove external components. MED-EL’s TICI platform has been followed by hearing healthcare professionals during development, with feasibility results and early European surgeries preceding this product announcement, according to The Hearing Review.
MED-EL is a privately held hearing implant company headquartered in Innsbruck, Austria. It makes cochlear, middle ear, bone conduction and auditory brainstem implants. The report also notes recent company activity in gene therapy programs and device connectivity, but does not link those developments to TICI Unico’s launch.
““TICI Unico is a new category of an implant. It is totally new and it is the realization of a dream that I have had for a very long time.””
— Ingeborg Hochmair, MED-EL co-founder and CEO
Access and Performance Details Pending
The report does not state when or where TICI Unico will be available, which patients will qualify, or what regulatory approvals have been granted. It also provides no pricing, clinical outcome data, safety information, battery or charging specifications, or independent comparisons with existing cochlear implants. MED-EL’s descriptions of the device’s invisibility and water use are company statements in the material provided.
Availability and Clinical Evidence
The next details readers and prospective patients will need are MED-EL’s rollout schedule, eligibility criteria, regulatory status and guidance on daily use. Further clinical information could clarify hearing outcomes, device reliability and how the implant handles charging and maintenance. The source report points readers to MED-EL for additional product information but does not give a date for a broader launch or name a next clinical milestone.
Key Questions
What is MED-EL TICI Unico?
It is a cochlear implant designed to place its components, including the microphone, beneath the skin, without externally visible hardware during everyday use, according to MED-EL.
How does it differ from conventional cochlear implants?
Conventional implants use an external sound processor worn behind the ear or on the head. MED-EL says TICI Unico is designed to operate with its components fully implanted.
Can the implant be used while swimming or sleeping?
MED-EL says the design is intended for continuous use, including during sleep, showering and swimming. The report does not specify water-use limits or provide independent performance data.
When will TICI Unico be available, and who can receive it?
The source report does not give an availability date, launch locations, eligibility criteria or regulatory details. Those specifics remain unreported.
Source: rss
